Pharmafile Logo
Pharmafocus logo
Advanced Search
merckwindowweb

Keytruda falls hard at gastric cancer hurdle

December 18, 2017
Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

There was a time when PD-1/L1 immunotherapy treatments could do no wrong, blasting through indication after indication. However, the limits …

News
tesaro

New PARP inhibitor hits UK market, offering distinct advantage

December 18, 2017
Sales and Marketing AstraZeneca, Novartis, Tesaro, Zejula, biotech, drugs, lynparza, pharma, pharmaceutical

Tesaro’s Zejula has been launched in the UK but availability on the NHS has still not been decided. The PARP …

News
celgene_exteriors-3

Cancer Research UK agrees largest drug discovery collab to date

December 15, 2017
Medical Communications, Research and Development Cancer Research UK, Celgene, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has announced that its subsidiary, Cancer Research Technology (CRT), and Celgene have agreed a drug discovery collaboration. …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …

News
teva_copy

Fierce local opposition to Teva’s restructure efforts

December 15, 2017
Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …

News
bruno-strigini-image

Novartis’ President of Oncology announces retirement

December 15, 2017
Medical Communications Bruno Strigini, Novartis, pharma

Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

News

BMS partners again with the company behind Opdivo

December 14, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has once again struck a deal with Ono Pharmaceutical for multiple programs, seeking to discover a boost to …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

Feature
bacteria-1777339_960_720

FDA launches new method for antibiotic prescription

December 14, 2017
Medical Communications antibiotic resistance, biotech, drugs, pharma, pharmaceutical

The fight against the growth of antibiotic resistance has become a major talking point internationally in recent years and the …

News
blood-75301_640

‘Mind-blowing’ gene therapy could herald a cure for haemophilia, study shows

December 14, 2017
Research and Development haemophilia, pharma

A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a …

News

What will Pfizer do with its second Remicade biosimilar?

December 14, 2017
Sales and Marketing Ixifi, Johnson & Johnson, Pfizer, Remicade, biosimilars, biotech, drugs, inflectra, pharma, pharmaceutical

Pfizer is now in the unusual position of owning two biosimilars to Johnson & Johnson’s Remicade, though one of these …

News
daiichi-sankyo-us

Daiichi Sankyo: Two steps forward, one step back in cancer deals

December 14, 2017
Sales and Marketing Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical

Daiichi Sankyo had a busy day in terms of its deals in oncology, not only did it tear up its …

News
mundipharma_4_204_of_291

Mundipharma names new President and CEO

December 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, Napp, Napp Pharmaceuticals, appointment

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …

Appointment

Sanofi sees pipeline fruition in 2018

December 13, 2017
Research and Development Sanofi, biotech, drugs, pharma, pharmaceutical

In news that Sanofi will no doubt be hoping should divert attention away from the Dengvaxia scandal, the company revealed …

News
shutterstock_159488225

Blood cancer patients over 75 are significantly underrepresented in clinical trials, study finds

December 13, 2017
Research and Development FDA, blood cancer, leukaemia, lymphoma, myeloid leukaemia, pharma

The FDA’s first comprehensive analysis of clinical trial enrolment in older patients with blood cancers has revealed that the population …

News
cocoa-174872_960_720

FDA cracks down on snortable chocolate powder

December 13, 2017
Medical Communications, Research and Development FDA, biotech, drugs, pharma, pharmaceutical

The FDA has taken action on Coco Loko and Legal Lean Syrup, both made by Arco Globus Trading LLC, after …

News

J&J’s Darzalex cuts risk of disease progression and death by 50%, new study shows

December 13, 2017
Research and Development Genmab, J&J, JJ, Janssen, Johnson & Johnson, darzalex, multiple myeloma, pharma

Johnson and Johnson has revealed data which demonstrates that Darzalex (daratumumab), when combined with a regimen of bortezomib, melphalan and …

News
teva_canada

Tumultuous times at Teva continue, with Chairman exit

December 13, 2017
Medical Communications, Research and Development Teva, biotech, drugs, pharma, pharmaceutical

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026